Literature DB >> 16755310

The Canadian Hypertension Education Program--a unique Canadian initiative.

F A McAlister1.   

Abstract

While almost two-thirds of all strokes and one-half of all myocardial infarctions could be prevented if hypertensive individuals had their blood pressures optimally controlled, only a minority of hypertensive individuals (even in publicly funded health care systems with subsidization of medication costs) achieve target blood pressures. Traditional hypertension guidelines have had limited impact on hypertension management and control rates. As a result, the Canadian Hypertension Education Program was developed to address the perceived flaws in the traditional hypertension guideline approach. In the present article, the key features of the Canadian Hypertension Education Program methodology are reviewed, with attention to those factors thought to be critical to the successful translation of recommendations into practice.

Entities:  

Mesh:

Year:  2006        PMID: 16755310      PMCID: PMC2560862          DOI: 10.1016/s0828-282x(06)70277-x

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  22 in total

Review 1.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

2.  Drug spending in Canada: recent trends and causes.

Authors:  Steve Morgan
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

3.  From knowledge to practice in chronic cardiovascular disease: a long and winding road.

Authors:  Sumit R Majumdar; Finlay A McAlister; Curt D Furberg
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

4.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.

Authors:  E M Antman; J Lau; B Kupelnick; F Mosteller; T C Chalmers
Journal:  JAMA       Date:  1992-07-08       Impact factor: 56.272

5.  Blood pressure as a cardiovascular risk factor: prevention and treatment.

Authors:  W B Kannel
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

6.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

7.  Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.

Authors:  Norman R C Campbell; Finlay A McAlister; Rollin Brant; Mitch Levine; Denis Drouin; Ross Feldman; Robert Herman; Kelly Zarnke
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

8.  Hypertension treatment and control in five European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; Holly Kramer; José R Banegas; Simona Giampaoli; Michel R Joffres; Neil Poulter; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

9.  Hypertension guidelines in elderly patients: is anybody listening?

Authors:  Karen Tu; Muhammad M Mamdani; Jack V Tu
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

View more
  28 in total

1.  Hypertension revisited.

Authors:  Norm R C Campbell; Richard E Gilbert; Lawrence A Leiter; Pierre Larochelle; Sheldon Tobe; Arun Chockalingam; Richard Ward; Dorothy Morris; Ross T Tsuyuki; Stewart Harris
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

2.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

Review 3.  Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.

Authors:  Doreen M Rabi; Raj Padwal; Sheldon W Tobe; Richard E Gilbert; Lawrence A Leiter; Robert R Quinn; Nadia Khan
Journal:  CMAJ       Date:  2013-06-03       Impact factor: 8.262

4.  Hypertension management in Canada: good news, but important challenges remain.

Authors:  Sailesh Mohan; Norm R C Campbell
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262

Review 5.  Surgical, interventional, and device innovations in the management of hypertension.

Authors:  Sibu P Saha; Khaled M Ziada; Thomas F Whayne
Journal:  Int J Angiol       Date:  2015-03

6.  Blood Pressure Control in Canada: Through the Looking-Glass Into a Glass Half Empty?

Authors:  Raj Padwal; Norm R C Campbell
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

Review 7.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

Authors:  Robert R Quinn; Brenda R Hemmelgarn; Raj S Padwal; Martin G Myers; Lyne Cloutier; Peter Bolli; Donald W McKay; Nadia A Khan; Michael D Hill; Jeff Mahon; Daniel G Hackam; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Finlay A McAlister; Maxime Lamarre-Cliche; Donna McLean; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Arun Chockalingam; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

Review 8.  Hypertension: are you and your patients up to date?

Authors:  Selina Omar Allu; Jocelyne Bellerive; Robin L Walker; Norm R C Campbell
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

Review 9.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Authors:  Daniel G Hackam; Nadia A Khan; Brenda R Hemmelgarn; Simon W Rabkin; Rhian M Touyz; Norman R C Campbell; Raj Padwal; Tavis S Campbell; M Patrice Lindsay; Michael D Hill; Robert R Quinn; Jeff L Mahon; Robert J Herman; Ernesto L Schiffrin; Marcel Ruzicka; Pierre Larochelle; Ross D Feldman; Marcel Lebel; Luc Poirier; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Luc Trudeau; Simon L Bacon; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Jean-Martin Boulanger; Mukul Sharma; Pavel Hamet; George Fodor; George K Dresser; S George Carruthers; George Pylypchuk; Ellen D Burgess; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Richard E Gilbert; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Philip A McFarlane; Robert A Hegele; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2010-05       Impact factor: 5.223

Review 10.  The systematic guideline review: method, rationale, and test on chronic heart failure.

Authors:  Christiane Muth; Jochen Gensichen; Martin Beyer; Allen Hutchinson; Ferdinand M Gerlach
Journal:  BMC Health Serv Res       Date:  2009-05-08       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.